Medscape6d
Inflammation Now the Key Target for Seborrheic Dermatitis
Topical antifungals, although often effective, are being discouraged in the early treatment of seborrheic dermatitis now that ...
LEADERSHIP Newspaper1h
Demystifying Common Skin Conditions, Treatment Options
Our skin works tirelessly to protect us, yet when it faces a condition, it can feel frustrating and overwhelming. Skin issues ...
CAGE Bio Announces Phase 2b Trial for CGB-500 (1% Tofacitinib), a Breakthrough Topical JAK Inhibitor for Moderate to Severe Atopic Dermatitis
SAN CARLOS, CA and FORT WORTH, TX / ACCESSWIRE / January 9, 2025 / CAGE Bio, Inc., a clinical-stage biotechnology company ...
Rolling Out4d
New hope for stubborn eczema sufferers
From atopic dermatitis to contact dermatitis, discover expert-backed treatments and lifestyle changes that can help manage ...
Cases of 'winter itch' condition set to rise as cold snap continues
Winter itch is a type of dermatitis - also known as pruritus hiemalis - that mostly occurs when the outdoor temperature drops ...
PharmiWeb2d
CAGE Bio Announces Phase 2b Trial for CGB-500 (1%…
SAN CARLOS, CA and FORT WORTH, TX / ACCESSWIRE / January 9, 2025 / CAGE Bio, Inc., a clinical-stage biotechnology company advancing innovative therapies for high incidence immuno-dermatological ...
Nektar completes enrollment in REZOLVE-AD Phase 2b study of rezpegaldesleukin
Therapeutics announced the company has completed target enrollment in its REZOLVE-AD Phase 2b study of rezpegaldesleukin in ...
Amgen: Blockbusters, Emerging Therapies, And Investment Potential
Amgen has a strong product portfolio, pipeline developments, and robust financial health. Read why AMGN stock is a Strong Buy ...
Best creams for psoriasis, as recommended by a dermatologist
Best creams for psoriasis, as recommended by a dermatologist - Dr Armstrong reveals the ingredients and formulas to turn to ...